Stefanović V, Toncheva D, Atanasova S, Polenaković M (2006) Etiology of Balkan endemic nephropathy and associated urothelial cancer. Am J Nephrol 26: 1-11.
Bamias J, Boletis J (2008) Balkan nephropathy: evolution of our knowledge. Am J Kidney Dis 52: 606-616.
Opinion of the Scientific Panel on Contaminants in the Food Chain on a request from the Commission related to ochratoxin A in food, adopted on 4 April 2006, The EFSA Journal 365: 1-56.
Depierreux M, Van Damme B, Vanden Houte K, Vanherweghem JL (1994) Pathologic aspects of a newly described nephropathy related to the prolonged use of Chinese herbs. Am J Kidney Dis 24: 172-180.
Vanherweghem JL, Depierreux M, Tielemans C, Abramowicz D, Dratwa M, et al. (1993) Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs. Lancet 341: 387-391.
Debelle FD, Vanherweghem JL, Nortier JL (2008) Aristolochic acid nephropathy: a worldwide problem. Kidney Int 74: 158-169.
Nortier JL, Martinez MC, Schmeiser HH, Arlt VM, Bieler CA, et al. (2000) Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). N Engl J Med 342: 1686-1692.
Grollman AP, Shibutani S, Moriya M, Miller F, Wu L, et al. (2007) Aristolochic acid and the etiology of endemic (Balkan) nephropathy. Proc Natl Acad Sci U S A 104: 12129-12134.
Stiborová M, Frei E, Arlt VM, Schmeiser HH (2008) Metabolic activation of carcinogenic aristolochic acid, a risk factor for Balkan endemic nephropathy. Mutat Res 658: 55-67.
Grollman AP, Jelaković B (2007) Role of environmental toxins in endemic (Balkan) nephropathy. October 2006, Zagreb, Croatia. J Am Soc Nephrol 18: 2817-2823.
Ivić M (1969) Etiology of endemic nephropathy. Lijec Vjesn 91: 1273-1281.
Hranjec T, Kovac A, Kos J, Mao W, Chen JJ, et al. (2005) Endemic nephropathy: the case for chronic poisoning by aristolochia. Croat Med J 46: 116-125.
Lindon JC, Nicholson JK, Holmes E, Antti H, Bollard ME, et al. (2003) Contemporary issues in toxicology the role of metabonomics in toxicology and its evaluation by the COMET project. Toxicol Appl Pharmacol 187: 137-146.
Lindon JC, Holmes E, Bollard ME, Stanley EG, Nicholson JK (2004) Metabonomics technologies and their applications in physiological monitoring, drug safety assessment and disease diagnosis. Biomarkers 9: 1-31.
Shockcor JP, Holmes E (2002) Metabonomic applications in toxicity screening and disease diagnosis. Curr Top Med Chem 2: 35-51.
Chen M, Su M, Zhao L, Jiang J, Liu P, et al. (2006) Metabonomic study of aristolochic acid-induced nephrotoxicity in rats. J Proteome Res 5: 995-1002.
Zhang X, Wu H, Liao P, Li X, Ni J, et al. (2006) NMR-based metabonomic study on the subacute toxicity of aristolochic acid in rats. Food Chem Toxicol 44: 1006-1014.
Mantle P, Modalca M, Nicholls A, Tatu C, Tatu D, et al. (2011) Comparative 1 H-NMR Metabolomic Urinalysis of People Diagnosed with Balkan Endemic Nephropathy, and Healthy Subjects, in Romania and Bulgaria: A Pilot Study. Toxins 3: 815-833.
Grosse Y, Baan R, Straif K, Secretan B, El Ghissassi F, et al. (2009) A review of human carcinogens-Part A: pharmaceuticals. Lancet Oncol 10: 13-14.
Cosyns JP, Jadoul M, Squifflet JP, Van Cangh PJ, van Ypersele de Strihou C (1994) Urothelial malignancy in nephropathy due to Chinese herbs. Lancet 344: 188.
Jelaković B, Karanović S, Vuković-Lela I, Miller F, Edwards KL, et al. (2012) Aristolactam-DNA adducts are a biomarker of environmental exposure to aristolochic acid. Kidney Int 81: 559-567.
De Broe ME (2012) Chinese herbs nephropathy and Balkan endemic nephropathy: toward a single entity, aristolochic acid nephropathy. Kidney Int 81: 513-515.
Debelle FD, Nortier JL, de Prez EG, Garbar CH, Vienne AR et al. (2002) Aristolochic acids induce chronic renal failure with interstitial fibrosis in salt-depleted rats. J Am Soc Nephrol 13: 431-436.
Pozdzik AA, Salmon IJ, Debelle FD, Decaestecker C, Van den Branden C, et al. (2008) Aristolochic acid induces proximal tubule apoptosis and epithelial to mesenchymal transformation. Kidney Int 73: 595-607.
Beckonert O, Bollard ME, Ebbels TMD, Keun HC, Antti H, et al. (2003) NMR-based metabonomic toxicity classification: hierarchical cluster analysis and k-nearest-neighbour approaches. Analytica Chimica Acta 490: 3-15.
Keun HC (2006) Metabonomic modeling of drug toxicity. Pharmacol Ther 109: 92-106.
Lindon JC, Keun HC, Ebbels TM, Pearce JM, Holmes E, et al. (2005) The Consortium for Metabonomic Toxicology (COMET): aims, activities and achievements. Pharmacogenomics 6: 691-699.
Lenz EM, Bright J, Wilson ID, Morgan SR, Nash AF (2003) A 1H-NMR-based metabonomic study of urine and plasma samples obtained from healthy human subjects. J Pharm Biomed Anal 33: 1103-1115.
Walsh MC, Brennan L, Malthouse JPG, Roche HM, Gibney MJ (2006) Effect of acute dietary standardization on the urinary, plasma, and salivary metabolomic profiles of healthy humans1,2,3. Am J Clin Nutr 84: 531-539.
Ouedraogo M, Baudoux T, Stévigny C, Nortier J, Colet JM, et al. (2012) Review of current and "omics" methods for assessing the toxicity (genotoxicity, teratogenicity and nephrotoxicity) of herbal medicines and mushrooms. J Ethnopharmacol 140: 492-512.
